
Genhelpsp. z o.o.
Other professional, scientific and technical activities not elsewhere classified
Overview
Genhelp is the official Polish distributor of 3DMed equipment and reagents for genetic testing. Its products include the Andis 350 automated DNA/RNA isolation system, the Andis 500 NGS library preparation system, and reagents for these processes.
Financials
Revenue history (in k)
Filing timeliness
1 of 3 financial statements was filed late (for 2023, 17 days late).
- 202523/06/2026
- 202415/07/2025
- 202301/08/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- DNA and RNA isolation system
- NGS library preparation system
- DNA and RNA isolation reagents
- NGS library preparation reagents
- Genetic research equipment
Website technology
- Online shop
- WooCommerce
- Website
- WordPress
- Elementor
Public procurement
1 tender recorded as contractor, with a total value of $709,692.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Apr 1, 2026 | Successive supply of materials, small single-use laboratory equipment and software licences for the analysis and classification of genetic variants. | $354.8K$354,846 | Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii | |
| Mar 31, 2026 | Successive supply of materials, small single-use laboratory equipment and software licences for the analysis and classification of genetic variants. | $354.8K$354,846 | Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii |
Genhelp is the contractor in one public sector contract, worth USD 1.86k.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 1, 2026 | Reagents | $1,864 | Uniwersytet Medyczny Im. Karola Marcinkowskiego w Poznaniu |
Trademarks
Genhelp holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2023.
| Mark | Protected until | |
|---|---|---|
| GENHELP(word) | Dec 4, 2033 |
Authorized Representatives
Manner of representation
The management board conducts the affairs of the company and represents the company externally. The management board may be a one-person management board or a multi-member management board. In the case of a multi-member management board, declarations on behalf of the company require the joint action of two members of the management board, or one member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Paweł Artur Szwagrzykage 61 | 80 | $2,160.99 | 80% |
Sławomir Szwagrzykage 62 | 20 | $540.25 | 20% |
Paweł Artur Szwagrzyk and Sławomir Szwagrzyk hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-07-14.
61 1600 1462 1736 1250 4000 0003
72 1090 1069 0000 0001 6108 4194
34 1600 1462 1736 1250 4000 0004
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Molgendiasp. z o.o. | $276,204.20 | molgendia.pl |
FAQ
Last updated: 2026-06-23